Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Finished Goods (2018 - 2025)

Immucell's Finished Goods history spans 8 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Finished Goods rose 19498.13% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, up 19498.13%, while the annual FY2025 figure was $1.9 million, 19498.13% up from the prior year.
  • Finished Goods reached $1.9 million in Q4 2025 per ICCC's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.0 million in Q3 2025 to a low of $9530.0 in Q4 2024.
  • Average Finished Goods over 5 years is $569077.0, with a median of $402619.0 recorded in 2023.
  • Peak YoY movement for Finished Goods: plummeted 97.63% in 2024, then soared 19498.13% in 2025.
  • A 5-year view of Finished Goods shows it stood at $29381.0 in 2021, then surged by 410.04% to $149855.0 in 2022, then soared by 168.67% to $402619.0 in 2023, then tumbled by 97.63% to $9530.0 in 2024, then skyrocketed by 19498.13% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Finished Goods are $1.9 million (Q4 2025), $2.0 million (Q3 2025), and $1.2 million (Q2 2025).